Search | Griddixdog

Subodh Adke added blog Networking
2026-05-05 12:09:56 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Comments 0 Shares 815 Views 0 Reviews

Please log in to like, share and comment!
Subodh Adke added blog Networking
2026-05-05 12:10:22 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Comments 0 Shares 890 Views 0 Reviews

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-07-02 07:39:33 -

Pharmaceutical CRO Market Competitive Analysis and Key Players
The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...

0 Comments 0 Shares 29 Views 0 Reviews

Please log in to like, share and comment!
Subhayan Mayra added blog Other
2026-05-26 12:44:21 -

AI Clinical Trial Market Growing at 15% CAGR Through 2034
According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...

0 Comments 0 Shares 953 Views 0 Reviews

Please log in to like, share and comment!